Business Context and Reporting Period
This Form 8-K was filed by DaVita HealthCare Partners Inc. on November 10, 2015. The report concerns a legal event involving RMS Lifeline, Inc., a wholly owned subsidiary operating as "Lifeline Vascular Access," which provides vascular access management services for dialysis patients but does not perform dialysis services.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a legal contingency and does not contain financial performance data.
Material Changes and Events
On November 10, 2015, Lifeline received a Civil Investigative Demand (CID) from the U.S. Department of Justice (DOJ). The investigation covers the period from January 1, 2008, through the present and relates to two vascular access centers in Florida. The DOJ is conducting a False Claims Act investigation, specifically reviewing the medical necessity of angiograms performed at these centers. The CID requests medical records for 10 patients among other documents.
Outlook, Risks, and Management Commentary
Management states that the Company maintains policies to promote compliance with the False Claims Act and intends to cooperate with the government. However, the Company explicitly states it cannot predict when the investigation will be resolved, its eventual outcome or scope, or its potential impact on the Company.
Investor Verification Checklist
- Verify the specific scope of the DOJ investigation regarding the two Florida vascular access centers.
- Monitor for future filings detailing the resolution or expansion of the Civil Investigative Demand.
- Assess the potential financial exposure related to the False Claims Act investigation, noting that no specific monetary impact is currently quantified.
- Confirm the status of the 10 patient records requested by the DOJ.